|
1. K C. Liao, H S. Chiu, S Y. Fan, Y D. Zeng, P H. Lu. A percutaneous fiber-optic biosensor for the immediate evaluation of chemotherapy efficacy in vivo (part I): strategy of assay design for monitoring inhomogeneously distributed biomarkers. Sensors and Actuator B: Chemical, 222, 544-550, 2016. 2. S Y. Fan, H S. Chiu, D Y. Lin, A. Liao, K C. Liao. Percutaneous fiber optic biosensor for immediate evaluation of chemotherapy efficacy in vivo (part II): in vitro and in vivo characterization. Sensors and Actuator B: Chemical, 222, 579-587, 2016. 3. K C. Liao, S C. Chang, C Y. Chiu, Y H. Chou. Acute response in vivo of a fiber-optic sensor for continuous glucose monitoring from canine studies on point accuracy. Sensors, 10, 7789-7802, 2010. 4. J. O’Kelly, K C. Liao, W. Clifton, D. Lu, P. Koeffler, G. Loeb. Percutaneous fiber-optic sensor for the detection of chemotherapy-induced apoptosis in vivo. Proc. SPIE, 7555, 75551H, 2010. 5. K C. Liao, T. Hogen-Esch, F J. Richmond, L. Marcu, W. Clifton, G E. Loeb. Percutaneous fiber-optic sensor for chronic glucose monitoring in vivo. Biosensors and Bioelectronics, 23, 1458-1465, 2008. 6. K C. Liao, T. Hogen-Esch, F J. Richmond, L. Marcu, W. Clifton, G E. Loeb. Design and fabrication of a disposable, percutaneous glucose sensors. Optical Fibers and Sensors for Medical Diagnostic and Treatment VI, SPIE Proc. 6083, 60830V, 2006. 7. K C. Liao, T. Hogen-Esch, F J. Richmond, L. Marcu, G E. Loeb. Design and fabrication of disposable, percutaneous chemical sensors. Optical Fibers and Sensors for Medical Application V, SPIE Proc. 5691, 129-145, 2005. 8. H L. Huang, P H. Lu, H C. Yang, G D. Lee, H R. Li, K C. Liao. Fiber-optic triggered release of liposome in vivo: implication of personalized chemotherapy. International Journal of Nanomedicine, 10, 5171-5185, 2015. 9. M. Mazumdar, A. Smith, L H. Schwartz. A statistical simulation study finds discordance between WHO criteria and RECIST guideline. Journal of Clinical Epidemiology, 57, 358-365, 2004. 10. W A. Berg, L. Gutierrez, M S. NessAiver, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology, 233, 830–849, 2004. 11. S G. Orel, M D. Schnall. MR imaging of the breast for the detection, diagnosis, staging of breast cancer. Radiology, 220, 13-30, 2001. 12. G J. Rodrigo. A cute Asthma in Adults: a review. Chest, 125, 1081, 2004. 13. J. Haller, D. Hyde, N. Deliolanis, R. de Kleine, M. Niedre, V. Ntziachristos. Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging. Journal of Applied Physiology, 104, 795-802, 2008. 14. V. Ntziachristos. Optical Imaging of Molecular Signatures in Pulmonary Inflammation. Proceedings of the American Thoracic Society, 6, 416-418, 2009. 15. A A. Neves, K M. Brindle. Assessing responses to cancer therapy using molecular imaging. Biochimica et Biophysica Acta, 1766, 242-261, 2006. 16. P A. Ellis, I E. Smith, K. McCarthy, S. Detre, J. Salter, M. Dowsett. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet, 349, 849, 1997. 17. T. Takei, Y. Kuge, S. Zhao, et al. Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-Annexin V uptake and histologic findings in an experimental model. Journal of Nuclear Medicine, 45, 2083-2087, 2004. 18. J F. Tait, C. Smith, F G. Blankenberg. Structural requirements for in vivo detection of cell death with 99mTc-Annexin V. Journal of Nuclear Medicine, 46, 807-815, 2005. 19. M. Michael, I F. Tannock. Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. Canadian Medical Association Journal, 158, 1727-1734, 1998. 20. P. Therasse, S G. Arbuck, E A. Eisenhauer, J. Wanders, R S. Kaplan, L. Rubinstein, J. Verweij, M. Van Glabbeke, A T. Van Oosterom, M C. Christian, S G. Gwyther. New guidelines to evaluate the response to treatment in solid tumors. Journal of the National Cancer Institute, 92, 205-216, 1999. 21. R T. Skeel, S N. Khleif (2003). Handbook of Cancer Chemotherapy (6th ed.). Lippincott Williams & Wilkins, Section I. ISBN 0-7817-3629-3. 22. B. Chabner, D L. Longo (2005). Cancer Chemotherapy and Biotherapy: Principles and Practice (4th ed.). Philadelphia: Lippincott Willians & Wilkins, Section VII. ISBN 0-7817-5628-6. 23. J M. Schroder. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin-1 activity. Journal of Immunology, 139, 3474-3483, 1987. 24. J. Schmid, C. Wiessmann. Induction of mRNA for a serine protease and a beta- thromboglobulin-like protein in mitogen-simulated human leukocytes. Journal of Immunology, 139, 250-256, 1987. 25. J M. Wang. Chemokines, receptors, and their role in cardiovascular pathology. International Journal of Clinical and Laboratory Research, 28, 83-90, 1998. 26. M. Baggiolini, B. Dewald, B. Moser. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Advances in Immunology, 55, 97-179, 1994. 27. P M. Murphy, H L. Tiffany. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science, 253, 1280-1283, 1991. 28. S V. Deo, S. Hazarika, N. K Shukla, S. Kumar, M. Kar, A. Samaiya. Surgical management of skin cancers: experience from a regional cancer centre in North India. Indian Jouranl of Cancer, 42, 145-150, 2005. 29. J E. Visvader. Cells of origin in cancer. Nature, 469, 314-322, 2011. 30. I. Hussain, F M. Khan, M. Alam, B S. Khan. Clinicopathological analysis of malignant eyelid tumours in north-west Pakistan. Journal of Pakistan Medical Association, 63, 25-32, 2013. 31. M. Alam, D. Ratner. Cutaneous squamous-cell carcinoma. New England Journal of Medicine, 344, 975-983, 2001. 32. S. Chung. Basal cell carcinoma. Archives of Plastic Surgery, 39, 166–170, 2012. 33. B. Zbytek, J A. Carlson, J. Granese, J. Ross, M. C Mihm Jr, A. Slominski. Current concepts of metastasis in melanoma. Expert Review of Dermatology, 3, 569–585, 2008. 34. M. Mazumdar, A. Smith, L H. Schwartz. A statistical simulation study finds discordance between WHO criteria and RECIST guideline. Journal of Clinical Epidemiology, 57, 358-365, 2004. 35. C. Suzuki, H. Jacobsson, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitation. Radio Graphics, 28, 329-344, 2008. 36. A. Daponte, P A. Ascierto, A. Gravina, M. Melucci, S. Scala, A. Ottaiano, E. Simeone, G. Palmieris, G. Comella. Temozolomide and cisplatin in avdanced malignant melanoma. Anticancer Research, 25, 1441-1448, 2005. 37. H S. Chiu. Fiber-optical biosensing platform for real-time evaluation of chemotherapy efficacy in vivo. Graduate Institute of Biomedical Engineering, National Chung-Hsing University, 2014.
|